BRIEF

on Biotest AG (isin : DE0005227201)

Biotest AG Launches 12th Plasma Collection Centre in Germany

Stock price chart of Biotest AG (EBR:BIO) showing fluctuations.

Biotest AG has inaugurated its 12th plasma collection centre in Wuppertal, Germany, as part of its European network now comprising 38 centres. Located at Friedrichstrasse 33 on Karlsplatz, the new facility operates Monday through Friday, offering a modern, sustainable, and paperless plasma donation experience.

This development by Plasma Service Europe GmbH, a Biotest subsidiary, comes alongside the creation of 27 new jobs. Centre manager Anja Hirner highlighted the convenience for local donors, and Managing Director Henrik Oehme acknowledged the collective effort in this project amidst challenging conditions.

The opening ceremony saw participation from local governmental and business leaders, emphasizing plasma donation's critical role, especially post-pandemic. Keynote speeches remarked on the importance of reducing import dependency by increasing domestic plasma supplies. Furthermore, testimonials from patients reliant on plasma-derived medications underscored the life-altering impact of donations.

The plasma collected at the centre will be processed exclusively in Germany, ensuring high compliance with stringent quality and safety standards. This move aligns with Biotest's strategy to expand its own plasma collection capabilities across Europe.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Biotest AG news